C. Greiner
Impact in
- Psychiatry and Mental health top 1%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Epilepsy research and treatment
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
Papers in
-
- Pharmacogenetics and Drug Metabolism 6
- Treatment of Major Depression 5
-
- Schizophrenia research and treatment 4
- Co-authors
- Ekkehard Haen (9 shared papers)Markus Wittmann (4 shared papers)Allen S. Levine (1 shared paper)J H Eckfeldt (1 shared paper)Burkhard Emanuel Jabs (2 shared papers)Bruno Pfuhlmann (2 shared papers)Stefan Unterecker (2 shared papers)Jürgen Deckert (1 shared paper)
In The Last Decade
C. Greiner
15 papers receiving 2.1k citations
C. Greiner's Hit Papers
Peers
Comparison fields: 5 of 100
- Psychiatry and Mental health 887
- Biological Psychiatry 99
- Pharmacology 324
- Toxicology 97
- Pharmacology 438
Countries citing papers authored by C. Greiner
This map shows the geographic impact of C. Greiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Greiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Greiner more than expected).
Fields of papers citing papers by C. Greiner
This network shows the impact of papers produced by C. Greiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Greiner. The network helps show where C. Greiner may publish in the future.
Co-authors
The 20 scholars most cited alongside C. Greiner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017 Hit paper breakdown → | 2017 | 1088 |
| 2 | AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011 Hit paper breakdown → | 2011 | 737 |
| 3 | 2018 | 243 | |
| 4 | 2012 | 36 | |
| 5 | 2021 | 32 | |
| 6 | 2008 | 27 | |
| 7 | 1982 | 25 | |
| 8 | 2011 | 14 | |
| 9 | Wirkstoffkonzentrations-bestimmungen zur Therapieleitung : Ergänzung therapeutischer Referenzbereiche durch dosisbezogene Referenzbereiche | 2008 | 9 |
| 10 | 2011 | 6 | |
| 11 | [Successful treatment of diphenhydramine (AH3) poisoning in childhood with hemoperfusion]. | 1987 | 2 |
| 12 | 2007 | 2 | |
| 13 | 2008 | 2 | |
| 14 | 2011 | 1 | |
| 15 | 2009 | 1 | |
| 16 | 2009 | 0 |
About C. Greiner
C. Greiner is a scholar working on Pharmacology, Psychiatry and Mental health, Pharmacology, Pediatrics, Perinatology and Child Health and Complementary and alternative medicine, having authored 16 papers that have together received 2.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Treatment of Major Depression (5 papers), Schizophrenia research and treatment (4 papers), Pharmaceutical studies and practices (3 papers), Diet and metabolism studies (2 papers), Complementary and Alternative Medicine Studies (2 papers), Dermatology and Skin Diseases (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). The work is most often cited by research in Psychiatry and Mental health (887 citations), Biological Psychiatry (99 citations), Pharmacology (324 citations), Toxicology (97 citations) and Pharmacology (438 citations). C. Greiner has collaborated with scholars based in Germany, Austria and Italy. Frequent co-authors include Ekkehard Haen, Markus Wittmann, Allen S. Levine, J H Eckfeldt, Burkhard Emanuel Jabs, Bruno Pfuhlmann, Stefan Unterecker, Jürgen Deckert, Christoph Hiemke and Dieter Steinhilber. Their work appears in journals such as Pharmacopsychiatry, European Psychiatry, Clinical Chemistry, British Journal of Pharmacology and The World Journal of Biological Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.